Literature DB >> 31455978

[Rational staging and follow-up of colorectal cancer : Do guidelines provide further help?]

M S Juchems1, J Wessling2.   

Abstract

CLINICAL/METHODICAL ISSUE: Colorectal cancer is one of the most common malignant tumors. Preoperative imaging is crucial in rectal cancer as patients can only receive optimal treatment when accurate staging is performed. The N‑staging is often difficult with the available options and must be called into question as a staging parameter. STANDARD RADIOLOGICAL
METHODS: Endoscopic ultrasound (EUS) and magnetic resonance imaging (MRI) are particularly suitable for local staging. Multiparametric MRI with diffusion imaging is indispensable for tumor follow-up. METHODICAL INNOVATIONS: The assessment of infiltration of the mesorectal fascia is best accomplished using high-resolution MRI. In addition, extramural vascular infiltration (EMVI) has become established as another important prognostic factor. After neoadjuvant therapy and restaging of locally advanced rectal cancer, the identification and validation of prognostically relevant image parameters are prioritized. Multiparametric MRI of the rectum including diffusion imaging as well as the application of radiological and pathological scores (MR-TRG) are becoming increasingly more important in this context. ASSESSMENT: For the radiologist it is important to become familiar with indicators of the resectability of rectal cancer and to be able to reliably read prognostically relevant imaging parameters in the tumor follow-up. PRACTICAL RECOMMENDATIONS: For the practical application, the establishment of a fixed MRI protocol is essential. In addition to a guideline-compliant TNM classification, the radiologist must provide the clinician with information on infiltration of the mesorectal fascia and extramural vascular infiltration. The MR-TRGs are becoming increasingly more important in tumor follow-up.

Entities:  

Keywords:  Computed tomography; Guidelines; Imaging; Magnetic resonance imaging; Rectal cancer

Mesh:

Year:  2019        PMID: 31455978     DOI: 10.1007/s00117-019-0578-6

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  44 in total

1.  Comparative study of transrectal ultrasonography, pelvic computerized tomography, and magnetic resonance imaging in preoperative staging of rectal cancer.

Authors:  N K Kim; M J Kim; S H Yun; S K Sohn; J S Min
Journal:  Dis Colon Rectum       Date:  1999-06       Impact factor: 4.585

Review 2.  Surveillance after colorectal cancer resection.

Authors:  J M Berman; R J Cheung; D S Weinberg
Journal:  Lancet       Date:  2000-01-29       Impact factor: 79.321

3.  The role of transrectal ultrasound-guided biopsy in the postoperative follow-up of patients with rectal cancer.

Authors:  M Hünerbein; S Totkas; K T Moesta; C Ulmer; T Handke; P M Schlag
Journal:  Surgery       Date:  2001-02       Impact factor: 3.982

4.  Late locoregional recurrence in rectal carcinoma.

Authors:  S Merkel; T Meyer; J Göhl; W Hohenberger
Journal:  Eur J Surg Oncol       Date:  2002-11       Impact factor: 4.424

5.  Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery.

Authors:  R G Beets-Tan; G L Beets; R F Vliegen; A G Kessels; H Van Boven; A De Bruine; M F von Meyenfeldt; C G Baeten; J M van Engelshoven
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

Review 6.  Follow-up strategies for patients treated for non-metastatic colorectal cancer.

Authors:  G M Jeffery; B E Hickey; P Hider
Journal:  Cochrane Database Syst Rev       Date:  2002

7.  Routine use of transrectal ultrasound in rectal carcinoma: results of a prospective multicenter study.

Authors:  F Marusch; A Koch; U Schmidt; R Zippel; R Kuhn; S Wolff; M Pross; A Wierth; I Gastinger; H Lippert
Journal:  Endoscopy       Date:  2002-05       Impact factor: 10.093

8.  Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence.

Authors:  Sidney Winawer; Robert Fletcher; Douglas Rex; John Bond; Randall Burt; Joseph Ferrucci; Theodore Ganiats; Theodore Levin; Steven Woolf; David Johnson; Lynne Kirk; Scott Litin; Clifford Simmang
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

9.  Results of long-term follow-up after curative resection of Dukes A colorectal cancer.

Authors:  Matthias W Wichmann; Christian Müller; Hans M Hornung; Ulla Lau-Werner; Friedrich-Wilhelm Schildberg
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352

10.  Recurrence and survival after mesorectal excision for rectal cancer.

Authors:  S Bülow; I J Christensen; H Harling; O Kronborg; C Fenger; H J Nielsen
Journal:  Br J Surg       Date:  2003-08       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.